Loading provider…
Loading provider…
Internal Medicine Physician in Houston, TX
NPI: 1053356873Primary Employer
Physicians Referral Service
mdanderson.org
HQ Phone
Get M.D. Jianjun's Phone Numberphone_androidMobile
Get M.D. Jianjun's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
FL State Medical License
2021
GA State Medical License
2023 - 2027
TX State Medical License
2011 - 2027
AZ State Medical License
2023 - 2026
LA State Medical License
2023 - 2026
OK State Medical License
2023 - 2026
TN State Medical License
2023 - 2026
WA State Medical License
2023 - 2026
AL State Medical License
2023 - 2025
MS State Medical License
2023 - 2025
WI State Medical License
2009 - 2011

American Board of Internal Medicine
Medical Oncology
University of Kansas School of Medicine - Kansas City
kumc.edu
Medical School
Until 2006
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
2010 - 2013
University of Wisconsin Hospitals and Clinics
Residency • Internal Medicine
2006 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 45 | 141 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 15 | 15 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 13 |
Evolving systemic management of urothelial cancers.
Authors: Matthew Campbell, Omar Alhalabi, Ashish Kamat
Journal: Curr Opin Oncol
Publication Date: 2023-03-14
Authors: Elshad Hasanov, Nizar Tannir
Journal: Cancer J
Lead Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Pemetrexed Disodium